Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 4649461012 | Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| 4649462017 | Product containing precisely tivozanib (as tivozanib hydrochloride) 1.34 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| 5305121000052117 | tivozanib (som tivozanibhydroklorid) 1,34 mg, oral kapsel | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Is a | Tivozanib only product in oral dose form | true | Inferred relationship | Some | ||
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has precise active ingredient | Tivozanib hydrochloride | true | Inferred relationship | Some | 1 | |
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has basis of strength substance (attribute) | Tivozanib (substance) | true | Inferred relationship | Some | 1 | |
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
This concept is not in any reference sets